Oncologist Delhi NCR’s Post

𝐈𝐧𝐭𝐫𝐚𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐯𝐞 𝐑𝐚𝐝𝐢𝐚𝐭𝐢𝐨𝐧 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 | 𝐆𝐈𝐒 ✅ 𝗚𝗿𝗮𝗯 𝗣𝗗𝗙 𝗙𝗼𝗿 𝗠𝗼𝗿𝗲 𝗗𝗲𝘁𝗮𝗶𝗹𝘀 >> https://lnkd.in/gfPB-mvM The Intraoperative Radiation Therapy (IORT) Market is gaining significant momentum as it offers a highly targeted and effective approach to cancer treatment. IORT delivers a concentrated dose of radiation directly to a tumor site during surgery, minimizing exposure to surrounding healthy tissues and enhancing the precision of cancer eradication. 𝐆𝐥𝐨𝐛𝐚𝐥 𝐈𝐧𝐭𝐫𝐚𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐯𝐞 𝐑𝐚𝐝𝐢𝐚𝐭𝐢𝐨𝐧 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 By Product & Service Products Systems/Accelerators Applicators & After Loads Treatment Planning Systems Accessories Services By Technology Electron IORT Intraoperative Brachytherapy By Application Breast Cancer Brain Tumor Gastrointestinal Cancer Head & Neck Cancer Colorectal Cancer Endometrial & Cervical Cancer Lung Cancer Others #IntraoperativeRadiationTherapy #IORT #CancerTreatment #Oncology #MedicalInnovation #PrecisionMedicine #CancerCare #RadiationTherapy #HealthcareTechnology #PatientOutcomes #BreastCancer #ColorectalCancer #PancreaticCancer #OncologicalCare #HealthTech #PersonalizedMedicine #FutureOfHealthcare

#CAR_T_cell_Therapy : 𝑨 𝑵𝒆𝒘 𝑬𝒓𝒂 𝒊𝒏 𝑪𝒂𝒏𝒄𝒆𝒓 𝑰𝒎𝒎𝒖𝒏𝒐𝒕𝒉𝒆𝒓𝒂𝒑𝒚  ➡𝐂𝐥𝐢𝐜𝐤 𝐡𝐞𝐫𝐞 𝐟𝐨𝐫 𝐏𝐃𝐅 >> https://lnkd.in/g-JSZ5zy CAR T-cell therapy, or chimeric antigen receptor T-cell therapy, is an innovative form of #immunotherapy used to treat certain types of cancer. It involves modifying a patient's own immune cells, called T cells, to recognize and destroy cancer cells more effectively. Various forms of   #cancertreatment  are available, such as surgery, #chemotherapy and #radiotherapy ; however, #therapeutic advancements to boost the efficacy of #cancertreatment have led to the development of CAR T-cell therapy. #cartcelltherapy is a treatment modality where T cells are engineered. The engineered CAR T cell gets activated when it encounters an #antigen on a cancer cell. Activated CAR T cells multiply, and #cytokines and activated #tcells cause significant inflammation focused on the #cancer cell resulting in cell death. Hence, this is a widely known therapy for #cancerpatients . Due to its efficacy, the #therapy is fast becoming a standard cancer treatment. Hence, the increasing cancer incidence drives the demand for CAR T-cell therapy. 𝐃𝐫𝐢𝐯𝐞𝐫𝐬    1.  Increasing #Cancer Prevalence    2.  Rise in Awareness Regarding #cartcelltherapy    3.  Increasing R&D Activities and #clinicaltrials ✔️ 𝐋𝐚𝐭𝐞𝐬𝐭 𝐏𝐫𝐞𝐬𝐬 𝐑𝐞𝐥𝐞𝐚𝐬𝐞 : https://lnkd.in/dRhCKwi3 #chimericantigenreceptor #surgery #medicine #development #Abecma #antigen #healthcare #health #oncology #medicaltechno

#CAR_T_cell_Therapy : 𝑨 𝑵𝒆𝒘 𝑬𝒓𝒂 𝒊𝒏 𝑪𝒂𝒏𝒄𝒆𝒓 𝑰𝒎𝒎𝒖𝒏𝒐𝒕𝒉𝒆𝒓𝒂𝒑𝒚  ➡𝐂𝐥𝐢𝐜𝐤 𝐡𝐞𝐫𝐞 𝐟𝐨𝐫 𝐏𝐃𝐅 >> https://lnkd.in/d9xU9AAb CAR T-cell therapy, or chimeric antigen receptor T-cell therapy, is an innovative form of #immunotherapy used to treat certain types of cancer. It involves modifying a patient's own immune cells, called T cells, to recognize and destroy cancer cells more effectively. Various forms of  #cancertreatment are available, such as surgery, #chemotherapy  and #radiotherapy ; however, #therapeutic advancements to boost the efficacy of #cancertreatment have led to the development of CAR T-cell therapy. #cartcelltherapy is a treatment modality where T cells are engineered. The engineered CAR T cell gets activated when it encounters an #antigen on a cancer cell. Activated CAR T cells multiply, and #cytokines and activated #tcells cause significant inflammation focused on the #cancer cell resulting in cell death. Hence, this is a widely known therapy for #cancerpatients . Due to its efficacy, the #therapy is fast becoming a standard cancer treatment. Hence, the increasing cancer incidence drives the demand for CAR T-cell therapy. 𝐃𝐫𝐢𝐯𝐞𝐫𝐬    1.  Increasing #Cancer Prevalence    2.  Rise in Awareness Regarding #cartcelltherapy    3.  Increasing R&D Activities and #clinicaltrials ✔️ 𝐋𝐚𝐭𝐞𝐬𝐭 𝐏𝐫𝐞𝐬𝐬 𝐑𝐞𝐥𝐞𝐚𝐬𝐞 : https://lnkd.in/dRhCKwi3 #chimericantigenreceptor #surgery #medicine #development #Abecma #antigen #healthcare #health #oncology #medicaltechno

𝐶𝑜𝑛𝑔𝑟𝑎𝑡𝑢𝑙𝑎𝑡𝑖𝑜𝑛𝑠 𝑡𝑜 𝑃𝑟𝑜𝑓. 𝑍𝑎𝑙𝑐𝑚𝑎𝑛 𝑎𝑛𝑑 𝑐𝑜𝑙𝑙𝑒𝑎𝑔𝑢𝑒𝑠 𝑜𝑛 𝑡ℎ𝑒 𝑝𝑢𝑏𝑙𝑖𝑐𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑡ℎ𝑒𝑖𝑟 𝑎𝑟𝑡𝑖𝑐𝑙𝑒 𝑜𝑛 𝑡ℎ𝑒 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 𝑎𝑛𝑑 𝑠𝑎𝑓𝑒𝑡𝑦 𝑜𝑓 𝑎 𝑏𝑜𝑜𝑠𝑡𝑒𝑟 𝑑𝑜𝑠𝑒 𝑜𝑓 𝑟𝑎𝑑𝑖𝑜𝑡ℎ𝑒𝑟𝑎𝑝𝑦 𝑖𝑛 𝑝𝑎𝑡𝑖𝑒𝑛𝑡𝑠 𝑤𝑖𝑡ℎ 𝑛𝑜𝑛-𝑠𝑚𝑎𝑙𝑙-𝑐𝑒𝑙𝑙 𝑙𝑢𝑛𝑔 𝑐𝑎𝑛𝑐𝑒𝑟 𝑖𝑛 𝑡ℎ𝑒 𝐿𝑎𝑛𝑐𝑒𝑡 𝑂𝑛𝑐𝑜𝑙𝑜𝑔𝑦 𝑗𝑜𝑢𝑟𝑛𝑎𝑙. 𝑊𝑒 𝑎𝑟𝑒 𝑑𝑒𝑙𝑖𝑔ℎ𝑡𝑒𝑑 𝑡𝑜 ℎ𝑎𝑣𝑒 𝑐𝑜𝑛𝑡𝑟𝑖𝑏𝑢𝑡𝑒𝑑 𝑡𝑜 𝑡ℎ𝑒 𝑠𝑢𝑐𝑐𝑒𝑠𝑠 𝑜𝑓 𝑡ℎ𝑖𝑠 𝑎𝑟𝑡𝑖𝑐𝑙𝑒! 🫁 𝐍𝐨𝐧-𝐬𝐦𝐚𝐥𝐥 𝐜𝐞𝐥𝐥 𝐥𝐮𝐧𝐠 𝐜𝐚𝐧𝐜𝐞𝐫 (NSCLC) accounts for 80% of all lung cancers. They are adenocarcinomas in 65% of cases and squamous cell carcinomas in 20%. 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐨𝐩𝐭𝐢𝐨𝐧𝐬 depend on stage and the patient's overall condition. In stage III patients, the options are chemoradiotherapy, radiotherapy, surgery or more targeted treatments. However, the 𝐢𝐧𝐭𝐞𝐧𝐬𝐢𝐟𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐭𝐡𝐨𝐫𝐚𝐜𝐢𝐜 𝐫𝐚𝐝𝐢𝐚𝐭𝐢𝐨𝐧𝐬 is controversial in stage III patients. 🫁 The aim was therefore to evaluate the 𝐚𝐜𝐭𝐢𝐯𝐢𝐭𝐲 𝐚𝐧𝐝 𝐝𝐨𝐬𝐞 𝐬𝐚𝐟𝐞𝐭𝐲 𝐨𝐟 𝐜𝐨𝐦𝐩𝐥𝐞𝐦𝐞𝐧𝐭𝐚𝐫𝐲 𝐫𝐚𝐝𝐢𝐨𝐭𝐡𝐞𝐫𝐚𝐩𝐲 up to 74 Gy compared with standard radiotherapy (66 Gy). A total of 158 patients took part in the clinical trial. The 𝐫𝐚𝐭𝐞 𝐨𝐟 𝐥𝐨𝐜𝐚𝐥 𝐜𝐨𝐧𝐭𝐫𝐨𝐥 at 15 months 𝐰𝐚𝐬 𝐡𝐢𝐠𝐡𝐞𝐫 in the complementary radiotherapy group, while the proportion of grade 3-4 𝐬𝐢𝐝𝐞 𝐞𝐟𝐟𝐞𝐜𝐭𝐬 𝐰𝐚𝐬 𝐥𝐨𝐰𝐞𝐫 than in the control group, although non-significantly different. 🫁 These promising results underline the need for a 𝐫𝐚𝐧𝐝𝐨𝐦𝐢𝐳𝐞𝐝 𝐩𝐡𝐚𝐬𝐞 𝟑 𝐭𝐫𝐢𝐚𝐥 evaluating the effect of adjuvant radiotherapy in patients with stage 3 NSCLC. The article is already available on the journal's website! 𝐃𝐎𝐈: 𝟏𝟎.𝟏𝟎𝟏𝟔/𝐒𝟏𝟒𝟕𝟎-𝟐𝟎𝟒𝟓(𝟐𝟒)𝟎𝟎𝟑𝟐𝟎-𝟔 #research #recherche #santé #health #médecine #medical

#CAR_T_cell_Therapy : 𝑨 𝑵𝒆𝒘 𝑬𝒓𝒂 𝒊𝒏 𝑪𝒂𝒏𝒄𝒆𝒓 𝑰𝒎𝒎𝒖𝒏𝒐𝒕𝒉𝒆𝒓𝒂𝒑𝒚 ➡𝐂𝐥𝐢𝐜𝐤 𝐡𝐞𝐫𝐞 𝐟𝐨𝐫 𝐏𝐃𝐅 >> https://lnkd.in/guJHp-Re CAR T-cell therapy, or chimeric antigen receptor T-cell therapy, is an innovative form of #immunotherapy used to treat certain types of cancer. It involves modifying a patient's own immune cells, called T cells, to recognize and destroy cancer cells more effectively. Various forms of #cancertreatment are available, such as surgery, #chemotherapy and #radiotherapy ; however, #therapeutic advancements to boost the efficacy of #cancertreatment have led to the development of CAR T-cell therapy. #cartcelltherapy is a treatment modality where T cells are engineered. The engineered CAR T cell gets activated when it encounters an #antigen on a cancer cell. Activated CAR T cells multiply, and #cytokines and activated #tcells cause significant inflammation focused on the #cancer cell resulting in cell death. Hence, this is a widely known therapy for #cancerpatients . Due to its efficacy, the #therapy is fast becoming a standard cancer treatment. Hence, the increasing cancer incidence drives the demand for CAR T-cell therapy. 𝐃𝐫𝐢𝐯𝐞𝐫𝐬 1.  Increasing #Cancer Prevalence 2.  Rise in Awareness Regarding #cartcelltherapy 3.  Increasing R&D Activities and #clinicaltrials ✔️ 𝐋𝐚𝐭𝐞𝐬𝐭 𝐏𝐫𝐞𝐬𝐬 𝐑𝐞𝐥𝐞𝐚𝐬𝐞 : https://lnkd.in/dRhCKwi3 #chimericantigenreceptor #surgery #medicine #development #Abecma #antigen #healthcare #health #oncology #medicaltechno

#CAR_T_cell_Therapy : 𝑨 𝑵𝒆𝒘 𝑬𝒓𝒂 𝒊𝒏 𝑪𝒂𝒏𝒄𝒆𝒓 𝑰𝒎𝒎𝒖𝒏𝒐𝒕𝒉𝒆𝒓𝒂𝒑𝒚 ➡𝐂𝐥𝐢𝐜𝐤 𝐡𝐞𝐫𝐞 𝐟𝐨𝐫 𝐏𝐃𝐅 >>https://lnkd.in/dTj9Zw4G CAR T-cell therapy, or chimeric antigen receptor T-cell therapy, is an innovative form of #immunotherapy used to treat certain types of cancer. It involves modifying a patient's own immune cells, called T cells, to recognize and destroy cancer cells more effectively. Various forms of #cancertreatment are available, such as surgery, #chemotherapy and #radiotherapy ; however, #therapeutic advancements to boost the efficacy of #cancertreatment have led to the development of CAR T-cell therapy. #cartcelltherapy is a treatment modality where T cells are engineered. The engineered CAR T cell gets activated when it encounters an #antigen on a cancer cell. Activated CAR T cells multiply, and #cytokines and activated #tcells cause significant inflammation focused on the #cancer cell resulting in cell death. Hence, this is a widely known therapy for #cancerpatients . Due to its efficacy, the #therapy is fast becoming a standard cancer treatment. Hence, the increasing cancer incidence drives the demand for CAR T-cell therapy. 𝐃𝐫𝐢𝐯𝐞𝐫𝐬 1.  Increasing #Cancer Prevalence 2.  Rise in Awareness Regarding #cartcelltherapy 3.  Increasing R&D Activities and #clinicaltrials ✔️ 𝐋𝐚𝐭𝐞𝐬𝐭 𝐏𝐫𝐞𝐬𝐬 𝐑𝐞𝐥𝐞𝐚𝐬𝐞 : https://lnkd.in/dRhCKwi3 #chimericantigenreceptor #surgery #medicine #development #Abecma #antigen #healthcare #health #oncology #medicaltechno

https://lnkd.in/gK3gR4_m Read what eminent DR CHANDRAMOHAN K, MBBS, MS, MCh. (Surgical Oncology), SENIOR CONSULTANT – SURGICAL ONCOLOGY, has to say about COLON CANCER. He has an experience of more than 25 years as an oncosurgeon with RCC Trivandrum. Areas of Expertise: • Open & Minimally Invasive surgeries for Gastro-intestinal cancers (liver, pancreas, colorectal, stomach), Urological cancers (kidney, bladder), Thoracic cancers (esophagus, lung) and Female genital cancers (ovary, uterus, cervix) • Breast cancer - breast conservation surgeries, Oncoplastic surgeries • Oral, Thyroid, Head & Neck cancers • Skin cancer surgeries • Musculoskeletal tumours & sarcomas 𝗔𝗽𝗽𝗼𝗶𝗻𝘁𝗺𝗲𝗻𝘁𝘀 𝟬𝟰𝟳𝟭 𝟯𝟭𝟬𝟬 𝟭𝟬𝟬 𝗘𝗺𝗲𝗿𝗴𝗲𝗻𝗰𝘆 𝟬𝟰𝟳𝟭 𝟯𝟭𝟬𝟬 𝟭𝟬𝟭 https://lnkd.in/ggEupHkw appointments@spmedifort.com #Hospital #patientcare #spmedifortcares #youfirstalways #preventivehealth #tertiarycare #coloncancer #Breastcancer #breastconservation #Oncoplasticsurgeries #Oralcancer #Thyroidcancer #HeadNeckCancer #ovarycancer #uteruscancer #cervixcancer #Livercancer #pancreascancer #colorectalcancer #stomachcancer #kidneycancer #bladdercancer #Skincancer #Musculoskeletaltumours #sarcomas

#CAR_T_cell_Therapy : 𝑨 𝑵𝒆𝒘 𝑬𝒓𝒂 𝒊𝒏 𝑪𝒂𝒏𝒄𝒆𝒓 𝑰𝒎𝒎𝒖𝒏𝒐𝒕𝒉𝒆𝒓𝒂𝒑𝒚 ➡𝐂𝐥𝐢𝐜𝐤 𝐡𝐞𝐫𝐞 𝐟𝐨𝐫 𝐏𝐃𝐅 >>https://lnkd.in/dibH7yvs CAR T-cell therapy, or chimeric antigen receptor T-cell therapy, is an innovative form of #immunotherapy used to treat certain types of cancer. It involves modifying a patient's own immune cells, called T cells, to recognize and destroy cancer cells more effectively. Various forms of #cancertreatment are available, such as surgery, #chemotherapy and #radiotherapy ; however, #therapeutic advancements to boost the efficacy of #cancertreatment have led to the development of CAR T-cell therapy. #cartcelltherapy is a treatment modality where T cells are engineered. The engineered CAR T cell gets activated when it encounters an #antigen on a cancer cell. Activated CAR T cells multiply, and #cytokines and activated #tcells cause significant inflammation focused on the #cancer cell resulting in cell death. Hence, this is a widely known therapy for #cancerpatients . Due to its efficacy, the #therapy is fast becoming a standard cancer treatment. Hence, the increasing cancer incidence drives the demand for CAR T-cell therapy. 𝐃𝐫𝐢𝐯𝐞𝐫𝐬 1.  Increasing #Cancer Prevalence 2.  Rise in Awareness Regarding #cartcelltherapy 3.  Increasing R&D Activities and #clinicaltrials ✔️ 𝐋𝐚𝐭𝐞𝐬𝐭 𝐏𝐫𝐞𝐬𝐬 𝐑𝐞𝐥𝐞𝐚𝐬𝐞 : https://lnkd.in/dRhCKwi3 #chimericantigenreceptor #surgery #medicine #development #Abecma #antigen #healthcare #health #oncology #medicaltechno

Prostate Cancer Care 🔷 The Healthcare Team Managing prostate cancer requires a multidisciplinary team — Along with surgeons, urologists, oncologists, radiologists, nurses and others collaborate to design individualized treatment plans, ensuring a comprehensive, patient-centered care. 🔷 Treatment Beyond Surgery While radical prostatectomy is often the standard treatment option, many patients benefit from other treatment options such as active surveillance, radiotherapy, hormone therapy, chemotherapy, and newer systemic treatments like immunotherapy. The choice depends on factors such as the cancer stage, Gleason score, and overall patient health. 🔷 Making Treatment Decisions Treatment choice is largely guided by disease stage, Gleason score, PSA levels, and patient overall health. For patients with localized low-risk disease, active surveillance may be more favorable, whereas more aggressive treatments are necessary for advanced or high-risk disease. Engaging patients in decision-making ensures their preferences and quality of life are prioritized. 🔷 Post-Treatment Expectations Late or long-term effects (such as urinary incontinence, erectile dysfunction, or bowel dysfunction) may occur post-treatment. Regular follow-ups are key to managing these long-term effects and monitoring PSA levels to detect potential recurrence. 🔷 Recurrence Following curative treatment, close monitoring of PSA levels is essential — Early detection through PSA monitoring can significantly enhance patient outcomes. If prostate cancer recurs, treatment options may include salvage radiotherapy, androgen deprivation therapy, brachytherapy, etc. #Empower_Men #Blue_ribbon #ProstateCancerAwarenessCampaign #prostate_cancer_awareness_month #September #SudanStandsStrong #Healthy_Sudanese_men #SudanFightsProstateCancer #Health_in_Sudan #SCSD #Sudan

“The treatment of prostate cancer has clinically not changed in the last 40 years, although significant new technologies have been developed. So the standard of care for prostate cancer is either remove the whole prostate or you kill it in its place through radiation. As we all know, radiation kills tissue. So when you're removing the prostate, it historically was done through open surgery.” Arun Menawat, CEO of Profound Medical Inc., explains how TULSA-PRO is changing the prostate cancer treatment landscape, helping men maintain their quality of life, in this informative interview on Fierce Biotech.